Fyodor is a growing revenue-generating biotech company at the forefront of developing and commercializing next generation novel medical diagnostic products that address major unmet global healthcare needs in emerging markets. We successfully developed and commercialized our flagship Urine Malaria Test (UMT) – the world’s first non-blood test that tells in 25 minutes or less if a fever is due to malaria or not. Seeking growth capital.